Lexpos News

/Lexpos News

MHRA Class 2 Medicines Recall: Phenobarbital Bristol Labs 15mg Tablets (Bristol Laboratories Ltd)

Drug alert number: EL (24)A/50 Date issued: 23 October 2024 Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles within the tablets. PL 17907/0175 DMRC Number: DMRC-32910584 SNOMED Code:21039211000001106 Batch No Expiry Date Pack Size First Distributed [...]

The post MHRA Class 2 Medicines Recall: Phenobarbital Bristol Labs 15mg Tablets (Bristol Laboratories Ltd) appeared first on Community Pharmacy England.

By |October 23rd, 2024|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Phenobarbital Bristol Labs 15mg Tablets (Bristol Laboratories Ltd)

Secretary of State launches national conversation on health service

The Secretary of State for Health and Social Care has this week launched a national conversation on the NHS, seeking input and ideas to shape the future of a reformed health service. Patients, members of the public and anyone working in the NHS have been invited to submit their views and ideas via the change.nhs.uk portal. [...]

The post Secretary of State launches national conversation on health service appeared first on Community Pharmacy England.

By |October 22nd, 2024|Lexpos News|Comments Off on Secretary of State launches national conversation on health service

October 2024 Price Concessions – 2nd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Agomelatine 25mg tablets 28 £13.50 Amitriptyline 50mg/5ml oral solution sugar free 150 [...]

The post October 2024 Price Concessions – 2nd Update appeared first on Community Pharmacy England.

By |October 22nd, 2024|Lexpos News|Comments Off on October 2024 Price Concessions – 2nd Update

National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup

National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup National Patient Safety Alert Reference Number: NatPSA/2024/011/DHSC Date issued: 21-Oct-2024 This NatPSA supersedes NatPSA/2024/008/DHSC This alert is for action by: All organisations involved in prescribing, dispensing and administering Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup. This is a safety critical [...]

The post National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup appeared first on Community Pharmacy England.

By |October 21st, 2024|Lexpos News|Comments Off on National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup

MHRA Class 4 Medicines Defect Information: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK)

MHRA Class 4 Medicines Defect Information: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) Drug alert number: EL(24)A/49 Date issued: 21 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) Company name: Kent Pharma UK Product name: Paracetamol [...]

The post MHRA Class 4 Medicines Defect Information: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) appeared first on Community Pharmacy England.

By |October 21st, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK)